tradingkey.logo

Australia's Althea rises on pharma asset sale, focus on North American operations

ReutersMay 7, 2025 5:32 AM

Shares of Althea Group Holdings AGH.AX rise 13% to A$0.026, set for strongest trading session since mid-April, if gains hold

The cannabis products maker to sell its pharmaceutical assets to private firm Tasmanian Botanics for A$1 million ($648,100)

Says divestment allows co to focus on cannabis-infused beverages market in North America

Adds that co's unit Peak USA successfully completed inaugural commercial manufacturing run in December 2024, a critical step in scaling U.S. operations

Around 916,000 shares change hands vs 30-day avg volume of 535,00 shares

Althea stock down 23.5% YTD, including current session's moves

($1 = 1.5430 Australian dollars)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI